Equities

BGM Group Ltd

BGM:NAQ

BGM Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)7.00
  • Today's Change0.00 / 0.00%
  • Shares traded9.57k
  • 1 Year change+208.91%
  • Beta1.4323
Data delayed at least 15 minutes, as of Nov 22 2024 17:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.

  • Revenue in USD (TTM)29.87m
  • Net income in USD-7.86m
  • Incorporated1970
  • Employees298.00
  • Location
    BGM Group LtdNo. 152 Hongliang East 1St StreetNo. 1703, Tianfu New DistrictJIUQUAN 610200ChinaCHN
  • Phone+86 9 372689523
  • Websitehttp://ir.qlsyy.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CEL-SCI Corp0.00-29.10m37.17m43.00--3.87-----0.5806-0.58060.000.15620.00-------100.88-70.19-124.78-78.31-------15,434.150.1793-36.790.5517------13.99--223.59--
Lexaria Bioscience Corp411.01k-4.85m37.70m5.00--3.37--91.72-0.4455-0.44550.04080.64030.0539--2.1682,202.00-63.85-95.67-65.93-96.5898.8376.98-1,185.15-1,612.76---64.960.00---11.43-12.198.31------
Tonix Pharmaceuticals Holding Corp11.29m-135.25m38.16m103.00--0.4282--3.38-52.81-52.810.64770.47680.09640.82914.05109,621.40-115.46-59.46-134.34-65.9220.74---1,197.86-5,126.732.78--0.0972------0.1874--320.57--
Earth Science Tech Inc26.89m2.33m39.78m32.0017.2612.4316.051.480.00760.00760.08780.01056.6523.99201.60840,435.9057.64-37.9879.28--71.3063.878.67-15.481.093.340.0241--24,526.3773.03322.25------
Fortress Biotech Inc62.50m-57.53m43.27m186.00--2.05--0.6924-3.53-3.533.740.7670.45022.166.70336,026.90-88.98-52.50-142.15-99.4660.5563.17-197.64-236.941.06-9.661.31--11.5825.7527.42---9.37--
United-Guardian, Inc.12.31m3.48m44.79m25.0012.863.9412.493.640.75850.75852.682.480.96844.747.44492,490.8027.4129.8431.5734.3953.4355.3128.3028.796.02--0.0097.37-14.28-4.140.4616-9.9217.19-19.73
Verrica Pharmaceuticals Inc9.21m-84.99m45.14m100.00------4.90-1.83-1.830.1979-0.74670.14161.674.6792,100.00-130.68-55.75-174.03-78.3374.08---922.81-754.941.22-10.163.82---43.27---173.59--5.65--
SCYNEXIS Inc8.57m-36.44m45.16m29.00--0.7715--5.27-0.756-0.7560.1771.540.0692--3.61295,379.30-29.44-30.02-35.54-36.35-71.42---425.41-86.76----0.1843--2,652.72252.64206.74------
Immix Biopharma Inc0.00-21.89m46.12m14.00--2.63-----0.8536-0.85360.000.63870.00----0.00-92.58---114.95--------------0.00-------87.44------
Odonate Inc0.00-102.07m49.87m137.00--1,839.01-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
BGM Group Ltd29.87m-7.86m50.59m298.00--1.15--1.69-1.10-1.104.186.070.52373.7325.96100,236.40-14.432.71-17.013.862.9211.66-27.562.726.06-0.75270.0026.11-28.35-1.60-822.64--12.86--
Aadi Bioscience Inc25.07m-61.69m56.20m53.00--0.8149--2.24-2.29-2.290.92852.800.22250.6964.09281,685.40-54.75-50.25-65.27-56.1587.39---246.06-473.974.54--0.00--60.063.85-8.68--153.54--
bluebird bio Inc53.12m-300.52m57.77m375.00------1.09-1.84-1.840.3039-0.02980.09852.034.42141,653.30-55.72-34.75-96.37-40.84-43.49-124.35-565.74-5,770.410.3272-13.371.03--720.04-11.588.00---30.47--
OptiNose Inc75.67m-31.15m59.56m132.00------0.787-0.2216-0.22160.5416-0.27250.65120.76592.96573,272.80-26.80-48.25---98.9590.2186.96-41.16-131.660.7198-1.611.48---6.9358.6452.58---27.96--
Data as of Nov 22 2024. Currency figures normalised to BGM Group Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley & Co. LLCas of 30 Sep 2024358.000.01%
Tower Research Capital LLCas of 30 Sep 202491.000.00%
UBS Securities LLCas of 30 Sep 20240.000.00%
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.